Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2841812 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Receptor Tyrosine Kinase-Like Orphan Receptor 2 (ROR2) (AA 19-50), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 19-50, N-Term
- Antibody clone number
- RB01507-01508
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.
The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
Distinct mutations in the receptor tyrosine kinase gene ROR2 cause brachydactyly type B.
Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B.
Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome.
Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2.
A novel family of cell surface receptors with tyrosine kinase-like domain.
Ma SS, Henry CE, Llamosas E, Higgins R, Daniels B, Hesson LB, Hawkins NJ, Ward RL, Ford CE
Virchows Archiv : an international journal of pathology 2017 Jan;470(1):99-108
Virchows Archiv : an international journal of pathology 2017 Jan;470(1):99-108
The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, French AD, Dissanayake SK, Indig FE, Bernier M, Taub DD, Hewitt SM, Weeraratna AT
Oncogene 2010 Jan 7;29(1):34-44
Oncogene 2010 Jan 7;29(1):34-44
Distinct mutations in the receptor tyrosine kinase gene ROR2 cause brachydactyly type B.
Schwabe GC, Tinschert S, Buschow C, Meinecke P, Wolff G, Gillessen-Kaesbach G, Oldridge M, Wilkie AO, Kömec R, Mundlos S
American journal of human genetics 2000 Oct;67(4):822-31
American journal of human genetics 2000 Oct;67(4):822-31
Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B.
Oldridge M, Fortuna AM, Maringa M, Propping P, Mansour S, Pollitt C, DeChiara TM, Kimble RB, Valenzuela DM, Yancopoulos GD, Wilkie AO
Nature genetics 2000 Mar;24(3):275-8
Nature genetics 2000 Mar;24(3):275-8
Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome.
van Bokhoven H, Celli J, Kayserili H, van Beusekom E, Balci S, Brussel W, Skovby F, Kerr B, Percin EF, Akarsu N, Brunner HG
Nature genetics 2000 Aug;25(4):423-6
Nature genetics 2000 Aug;25(4):423-6
Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2.
Afzal AR, Rajab A, Fenske CD, Oldridge M, Elanko N, Ternes-Pereira E, Tüysüz B, Murday VA, Patton MA, Wilkie AO, Jeffery S
Nature genetics 2000 Aug;25(4):419-22
Nature genetics 2000 Aug;25(4):419-22
A novel family of cell surface receptors with tyrosine kinase-like domain.
Masiakowski P, Carroll RD
The Journal of biological chemistry 1992 Dec 25;267(36):26181-90
The Journal of biological chemistry 1992 Dec 25;267(36):26181-90
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
